Cite
Hölttä V, Sipponen T, Westerholm-Ormio M, et al. In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells. ISRN Gastroenterol. 2012;2012:505432doi: 10.5402/2012/505432.
Hölttä, V., Sipponen, T., Westerholm-Ormio, M., Salo, H. M., Kolho, K. L., Färkkilä, M., Savilahti, E., Vaarala, O., & Klemetti, P. (2012). In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells. ISRN gastroenterology, 2012505432. https://doi.org/10.5402/2012/505432
Hölttä, Veera, et al. "In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells." ISRN gastroenterology vol. 2012 (2012): 505432. doi: https://doi.org/10.5402/2012/505432
Hölttä V, Sipponen T, Westerholm-Ormio M, Salo HM, Kolho KL, Färkkilä M, Savilahti E, Vaarala O, Klemetti P. In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells. ISRN Gastroenterol. 2012;2012:505432. doi: 10.5402/2012/505432. Epub 2012 Jun 14. PMID: 22778976; PMCID: PMC3384926.
Copy
Download .nbib